These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3490831)

  • 21. [Multicenter phase II study of the Liver Metastases Study Group of weekly intra-arterial 24-hour high dose therapy with 5-FU and folinic acid (FA) in liver metastases of colorectal tumors].
    Staib-Sebler E; Müller HH; Mattes P; Junginger T; Saeger HD; Lorenz M
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1441-4. PubMed ID: 9931906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Early phase II trial of l-leucovorin and 5-fluorouracil in advanced colorectal cancer. l-Leucovorin and 5-FU Study Group].
    Sugano K; Ota K; Taguchi T; Ogawa N; Kurihara M; Akazawa S; Ogawa M; Tominaga T; Sasaki T; Konishi T
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):627-37. PubMed ID: 7717714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intra-arterial 5-fluorouracil and intravenous folinic acid in the treatment of liver metastases from colorectal cancer.
    Howell JD; Warren HW; Anderson JH; Kerr DJ; McArdle CS
    Eur J Surg; 1999 Jul; 165(7):652-8. PubMed ID: 10452259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase I trial of a modified, dose intensive FAMTX regimen (high dose 5-fluorouracil+doxorubicin+high dose methotrexate+leucovorin) with oral uridine rescue.
    Schwartz GK; Christman K; Saltz L; Casper E; Quan V; Bertino J; Martin DS; Colofiore J; Kelsen D
    Cancer; 1996 Nov; 78(9):1988-95. PubMed ID: 8909321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetic modulating chemotherapy highly effective for colorectal carcinoma metastases to multiple organs].
    Muneoka K; Shirai Y; Wakai T; Yokoyama N; Okumura S; Hatakeyama K
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):799-802. PubMed ID: 15984519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of hepatic arterial infusion chemotherapy with 5-FU and leucovorin for unresectable liver metastases from colorectal cancer].
    Yamashita K; Urakami A; Kubota H; Nagatsuka R; Murakami H; Kawabe Y; Higashida M; Hirabayashi Y; Mikami Y; Ikeda M; Fuchimoto M; Yamamura M; Oka Y; Okumura H; Iki K; Matsumoto H; Imai S; Hirai T; Tsunoda T
    Gan To Kagaku Ryoho; 2008 Jan; 35(1):71-6. PubMed ID: 18195531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Late phase II trial of high-dose l-leucovorin and 5-fluorouracil in advanced colorectal carcinoma. l-Leucovorin and 5-FU Study Group (Japan Eastern Group)].
    Yoshino M; Ota K; Kurihara M; Akazawa S; Tominaga T; Sasaki T; Konishi T; Kodaira S; Kumai K; Sugano K
    Gan To Kagaku Ryoho; 1995 May; 22(6):785-92. PubMed ID: 7755386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of inoperable advanced gall bladder cancer responding to intra-arterial infusion of 5-fluorouracil (5-FU) and leucovorin (LV)].
    Ohta K; Sawamura A; Miyahara E; Kim R; Toge T
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):516-9. PubMed ID: 11329787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of combination chemotherapy to adapted to chronotherapy with 5-fluorouracil, leucovorin, mitomycin C and cisplatin in patients with gastric or colorectal cancer].
    Kamoshita N; Yokomori T; Iesato H; Ohya T; Nagaoka H; Okabe T; Kato Y; Takeyoshi I; Ohwada S; Morishita Y
    Gan To Kagaku Ryoho; 2000 May; 27(5):711-6. PubMed ID: 10832439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes of host immunity in relation to efficacy in liver cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy.
    Momiyama K; Nagai H; Sumino Y
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):271-7. PubMed ID: 19011857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Th1/Th2 balance: an important indicator of efficacy for intra-arterial chemotherapy.
    Nagai H; Miyaki D; Matsui T; Kanayama M; Higami K; Momiyama K; Ikehara T; Watanabe M; Sumino Y; Miki K
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):959-63. PubMed ID: 18259753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intra-arterial chemotherapy of local recurrences of gastrointestinal tumors].
    Heim ME
    Z Gastroenterol Verh; 1989 Jul; 24():194-5. PubMed ID: 2474950
    [No Abstract]   [Full Text] [Related]  

  • 33. [A case of angiosarcoma effectively treated with intra-arterial continuous infusion of anticancer agents].
    Fujioka A; Yasui Y; Baba S; Suzuki H; Morioka S; Iida T
    Nihon Hifuka Gakkai Zasshi; 1986 Sep; 96(10):1025-33. PubMed ID: 3795560
    [No Abstract]   [Full Text] [Related]  

  • 34. [New chances in therapy of gastrointestinal tumors].
    Krankenpfl J; 2005; 43(7-10):232. PubMed ID: 16515302
    [No Abstract]   [Full Text] [Related]  

  • 35. Intra-arterial infusion of 5-fluorouracil, leucovorin and cisplatin for primary adenocarcinoma of the urinary bladder.
    Awakura Y; Yamamoto M; Fukuzawa S; Nonomura M; Fukuyama T
    Int J Urol; 1999 Nov; 6(11):581-4. PubMed ID: 10585125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folinic acid (CF)/5-fluorouracil (FUra) combinations in advanced gastrointestinal carcinomas.
    Wilke H; Schmoll HJ; Preusser P; Fink U; Stahl M; Schöber C; Link H; Freund M; Hanauske A; Meyer HJ
    Adv Exp Med Biol; 1988; 244():233-43. PubMed ID: 3073658
    [No Abstract]   [Full Text] [Related]  

  • 37. Advances in folate chemotherapy: status of 5-fluorouracil/leucovorin in advanced malignancies. August 3, 1988, Cleveland, Ohio. Proceedings.
    Cancer; 1989 Mar; 63(6 Suppl):995-1053. PubMed ID: 2783882
    [No Abstract]   [Full Text] [Related]  

  • 38. Fluorouracil/leucovorin study update.
    Erlichman C
    J Clin Oncol; 1991 Nov; 9(11):2076. PubMed ID: 1941066
    [No Abstract]   [Full Text] [Related]  

  • 39. [New method for analysis of target molecule in gastrointestinal carcinoma--from the choice of ATP7B as a target molecule for overcoming drug resistance through the development of an inhibitor against ATP7B].
    Takebayashi Y; Kanzaki A; Higashimoto M; Sugeno H; Takenoshita S
    Nihon Shokakibyo Gakkai Zasshi; 2004 Jan; 101(1):18-26. PubMed ID: 14763152
    [No Abstract]   [Full Text] [Related]  

  • 40. Folic acid instead of leucovorin for 5-FU modulation?
    Ratner LH
    Oncology (Williston Park); 1988 Jan; 2(1):46. PubMed ID: 3275150
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.